Citation: Hw. Wechsel et al., Marker for renal cell carcinoma (RCC): The dimeric form of pyruvate kinasetype M-2 (Tu M2-PK), ANTICANC R, 19(4A), 1999, pp. 2583-2590
Authors:
Feil, G
Wechsel, HW
Nelde, HJ
Bichler, KH
Citation: G. Feil et al., Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas, ANTICANC R, 19(4A), 1999, pp. 2591-2597
Authors:
Feil, G
Leipoldt, M
Nelde, HJ
Wunderer, A
Wechsel, HW
Kaiser, P
Bichler, KH
Citation: G. Feil et al., Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma, ANTICANC R, 19(2C), 1999, pp. 1477-1482
Authors:
Wechsel, HW
Petri, E
Feil, G
Nelde, HJ
Bichler, KH
Loesr, W
Citation: Hw. Wechsel et al., Renal cell carcinoma: Immunohistological investigation of expression of the integrin alpha v beta 3, ANTICANC R, 19(2C), 1999, pp. 1529-1532
Authors:
Wechsel, HW
Feil, G
Lahme, S
Loeser, W
Bichler, KH
Citation: Hw. Wechsel et al., Plasma-inactive form of pyruvate kinase (pTuM2Pk) in renal cell carcinoma (RCC): An acceptable marker?, AKT UROL, 30(4), 1999, pp. 249-253